TCL Archive Letter to the Editors: Researchers Must Keep Up NIH Advocacy Particularly Now October 11, 1996
TCL Archive In Brief: Calabresi Named DCT Board Chairman; NCI Gets $5 Million Gifts for Intramural Breast Cancer Work June 20, 1986
TCL Archive Robert Young To Step Down As Fox Chase Cancer Center President in 2007. September 29, 2006
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005